Merck R&D chief Roger Perlmutter offers some heavyweight R&D glam to a little upstart biotech out to cure Duchenne MD
Back when Roger Perlmutter jumped into a leading role as R&D chief at Merck, one of the first things he did was bow out of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
